• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.60% Nasdaq Down 0.39%

    Stemline Therapeutics, Inc. (STML)

    -NasdaqCM
    4.26 Up 0.15(3.65%) Feb 11, 4:00PM EST
    Prev Close:4.11
    Open:4.02
    Bid:0.01 x 100
    Ask:11.00 x 100
    1y Target Est:32.00
    Beta:0.109571
    Earnings Date:Mar 11 - Mar 15 (Est.)
    Day's Range:4.02 - 4.39
    52wk Range:4.02 - 17.40
    Volume:42,807
    Avg Vol (3m):115,027
    Market Cap:76.68M
    P/E (ttm):N/A
    EPS (ttm):-2.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for STML

    Comparison

    Symbol% ChgMkt Cap
    STMLUp 3.65%76.68M
    OMEDUp 0.67%272.18M
    VSTMUp 0.89%41.74M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):126.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-2.14
    Quarterly EPS Est (Dec-15) :-0.57
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary therapeutics for cancer stem cells and bulk tumors in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback